Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2020-02-28 Board/Management Inform…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Appointment of new Non Executive Director
Board/Management Information Classification · 99% confidence The document is a formal announcement disseminated via 'RNS Number', which is the news service of the London Stock Exchange, indicating it is a regulatory filing. The core content announces the 'Appointment of Alison Platt as Non-Executive Director of Dechra Pharmaceuticals PLC'. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2020-02-28 English
Half-year Report - six months ended 31.12.19
Interim / Quarterly Report Classification · 100% confidence The document is a 'Half-Yearly Financial Report' for Dechra Pharmaceuticals PLC for the period ended 31 December 2019. It contains comprehensive financial statements, operational reviews, and detailed financial analysis (revenue, operating profit, EPS, etc.). It is not an announcement of a report (RPA) because it contains the actual substantive financial data and analysis. It fits the definition of an Interim/Quarterly Report (IR). H2 2020
2020-02-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 6686D' and contains the standard format for 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (crossing thresholds) by institutional investors or directors. This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2020-02-20 English
TR-1: Notification of Major Holdings
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled as an 'RNS Number' notification and uses the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (crossing thresholds) to the relevant regulatory body (FCA in this case). This directly corresponds to the definition of a Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2020-02-17 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details the 'Total Voting Rights' as of the announcement date (31 January 2020), which is a mandatory disclosure under DTR 5.6.1R. This type of routine regulatory notification, which doesn't fit into specific categories like earnings, dividends, or director dealings, is best classified under the general regulatory announcement category.
2020-01-31 English
Trading Update and Notice of Half Year Results
Regulatory Filings Classification · 98% confidence The document is explicitly labeled with an 'RNS Number' and contains a 'Trading Update' for the half-year reporting period (1 July to 31 December 2019). It provides key financial highlights (revenue growth percentages) and operational updates, but crucially, it states: 'Dechra will announce its Interim Results for the Period on 24 February 2020.' This indicates the document is a pre-results update, not the full Interim/Quarterly Report (IR) itself. Since it is a formal announcement released via the RNS system, and it contains financial highlights preceding the full report, it aligns best with the 'Earnings Release' (ER) category, which covers initial announcements of periodical financial results (key highlights only). It is not a full report, nor is it a general regulatory filing fallback, as it has a specific financial reporting purpose.
2020-01-16 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.